brandy

Transaction expected to combine Accelus and CHP Merger Corp., a leading healthcare-focused SPAC. The pro-forma enterprise value of the business combination would be approximately $482 million. Chris Walsh, Accelus CEO and Co-Founder, will become CEO of the combined company, Accelus. Mr. Walsh has 25 years of experience at leading spinal health companies, including Stryker and …

Accelus, an Emerging Leader in Minimally Invasive Spine Surgery, and CHP Merger Corp. Announce Proposed Business Combination Read More »

New 7mm insertion profile, combined with the company’s proprietary Adaptive Geometry technology, are designed to respect patients’ neural, vascular, bony and soft tissue anatomy both during and after insertion to promote long-term stability PALM BEACH GARDENS, Fla., August 17, 2021 (Globe Newswire) – Accelus, a privately held medical technology company focused on accelerating the adoption …

Accelus Launches Ultra-Low Profile FlareHawk7™ Expandable Cage Implant and Innovative Instruments to Support Endoscopic, MIS Lumbar Fusion Procedures Read More »